Our results identified that high expression of DYNLT1 predicted poor disease-specific survival (Figures 3C, D), relapse-free survival (Figures 3E–H), and distant metastasis-free survival (Figure 3I) in BC. This evidence concerns the gene DYNLT1 and breast cancer.